Does ACL Augmented With LEAT Better Controls Rotational Laxity Than Isolated ACL Reconstruction?

NCT ID: NCT04136990

Last Updated: 2022-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-13

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has been suggested that adding a Lateral Extra-Articular Tenodesis (LEAT) to Anterior Cruciate Ligament (ACL) reconstruction has the advantage of better controlling the rotational laxity. The objective of this study is to compare the the sagittal and rotational knee laxity using the Porto Knee Testing Device (PKTD) - a MRI-compatible arthrometer - at 2 years follow-up (side-to-side and to baseline comparison) in patients that underwent isolated ACL reconstruction (isolated ACL) versus ACL reconstruction combined with LEAT (ACL+LEAT). Patient-reported outcome measures using the Knee Injury and Osteoarthritis Outcome Score (KOOS) and graft failure (re-tear) will also be assessed at 2 years follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a non-randomized clinical trial including 40 patients with anterior cruciate ligament injury who are undergoing surgery and will be allocated 1:1 to either isolated ACL reconstruction (control group) or ACL reconstruction combined with lateral extra-articular tenodesis (experimental group). The principal outcome of this work is the sagittal and rotational knee laxity analysis and side-to-side and 2-year improvement. The secondary outcomes include graft failure (re-tears) and the patient-reported outcome measures (KOOS) at 2 years follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Cruciate Ligament Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Non-randomized 1:1 allocation
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Outcomes Assessor will be blinded to the patient group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Isolated ACL reconstruction

Isolated ACL reconstruction only.

Group Type ACTIVE_COMPARATOR

Isolated ACL reconstruction

Intervention Type PROCEDURE

Isolated ACL reconstruction using the bone-patellar tendon autograft.

ACL + LEAT

ACL reconstruction combined with Lateral Extra-Articular Tenodesis (LEAT).

Group Type EXPERIMENTAL

ACL + LEAT reconstruction

Intervention Type PROCEDURE

ACL reconstruction using the bone-patella-tendon-bone autograft combined with LEAT using the mini Lemaire technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isolated ACL reconstruction

Isolated ACL reconstruction using the bone-patellar tendon autograft.

Intervention Type PROCEDURE

ACL + LEAT reconstruction

ACL reconstruction using the bone-patella-tendon-bone autograft combined with LEAT using the mini Lemaire technique.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* no previous knee surgeries
* contralateral healthy knee
* positive pivot-shift (++)

Exclusion Criteria

* revision ACL surgery
* ACL reconstruction using allograft or synthetic grafts
* multi-ligament injury
* pregnant female
* other injuries or conditions that may alter the knee function (eg. severe osteoarthritis)
* requiring concomitant osteotomy
* requiring concomitant cartilage surgery (other than debridement)
Minimum Eligible Age

15 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Espregueira-Mendes Sports Centre - FIFA Medical Centre of Excellence

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

João Espregueira-Mendes, MD, PhD

Role: STUDY_DIRECTOR

Clínica do Dragão, Espregueira-Mendes Sports Centre - FIFA Medical Centre of Excellence

Renato Andrade

Role: PRINCIPAL_INVESTIGATOR

Clínica do Dragão, Espregueira-Mendes Sports Centre - FIFA Medical Centre of Excellence

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clínica do Dragão, Espregueira-Mendes Sports Centre - FIFA Medical Centre of Excellence

Porto, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0015/0019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long-term Follow up of the Stability 1 Trial
NCT06885372 ENROLLING_BY_INVITATION NA